TITLE:
Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

CONDITION:
Asthma

INTERVENTION:
MK0476, montelukast sodium / Duration of Treatment: 4 weeks

SUMMARY:

      The purpose of this study is to assess the efficacy and safety of an approved drug on asthma
      symptoms in patients with chronic asthma which is also active during the allergy season.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Asthma symptoms brought on by allergies

        Exclusion Criteria:

          -  Patient has any lung disease

          -  Currently have a sinus infection or cold symptoms
      
